Short-term expansion of breast circulating cancer cells predicts response to anti-cancer therapy. - Wikidata - awgldk - TriplyDB

Short-term expansion of breast circulating cancer cells predicts response to anti-cancer therapy.

Short-term expansion of breast circulating cancer cells predicts response to anti-cancer therapy.

http://www.wikidata.org/entity/Q35640863

about

Minimal residual disease in breast cancer: an overview of circulating and disseminated tumour cells Circulating tumor cells in breast cancer Circulating and disseminated tumor cells: diagnostic tools and therapeutic targets in motion Fibroblast Growth Factor Receptor 1 Gene Amplification in Nonsmall Cell Lung Cancer Enrichment and single-cell analysis of circulating tumor cells.Short term ex-vivo expansion of circulating head and neck tumour cells.Oncostatin M promotes cancer cell plasticity through cooperative STAT3-SMAD3 signaling.Aptamer-polymer functionalized silicon nanosubstrates for enhanced recovered circulating tumor cell viability and in vitro chemosensitivity testing FGFR inhibitors: Effects on cancer cells, tumor microenvironment and whole-body homeostasis (Review).CD68 and interleukin 13, prospective immune markers for esophageal squamous cell carcinoma prognosis prediction Liquid biopsy and therapeutic response: Circulating tumor cell cultures for evaluation of anticancer treatment.Impact of label-free technologies in head and neck cancer circulating tumour cells.Second-line therapy for small cell lung cancer: exploring the potential role of circulating tumor cells Cadherin-mediated cell-cell interactions in normal and cancer cells.A liquid biopsy for head and neck cancers.Phenotype of circulating tumor cell: face-off between epithelial and mesenchymal masks.Mesenchymal-Epithelial Transition and Circulating Tumor Cells in Small Cell Lung Cancer.Circulating tumor cell technologies.Clinical and biological significance of circulating tumor cells in cancer.Epithelial-mesenchymal plasticity and circulating tumor cells: Travel companions to metastases.The EMT spectrum and therapeutic opportunities.Materials and microfluidics: enabling the efficient isolation and analysis of circulating tumour cells.Isolation and detection of circulating tumour cells from metastatic melanoma patients using a slanted spiral microfluidic device.Expansion of patient-derived circulating tumor cells from liquid biopsies using a CTC microfluidic culture device.The AKT inhibitor triciribine in combination with paclitaxel has order-specific efficacy against Zfp217-induced breast cancer chemoresistance.Progress and challenges of sequencing and analyzing circulating tumor cells.Acute phase dynamics of circulating tumor cells after paclitaxel and doxorubicin chemotherapy in breast cancer mouse models.Epithelial-Mesenchymal Transition in Pancreatic Cancer: A Review.Clinical significance of detecting CSF-derived tumor cells in breast cancer patients with leptomeningeal metastasis.From Chemotherapy to Combined Targeted Therapeutics: In Vitro and in Vivo Models to Decipher Intra-tumor Heterogeneity.The viable circulating tumor cells with cancer stem cells feature, where is the way out?Intraoperative cell salvage in metastatic spine tumour surgery reduces potential for reinfusion of viable cancer cells.Human circulating and tissue gastric cancer stem cells display distinct epithelial-mesenchymal features and behaviors.Potential of circulating tumor cells as blood-based biomarkers in cancer liquid biopsy.Acquisition of tumor cell phenotypic diversity along the EMT spectrum under hypoxic pressure: Consequences on susceptibility to cell-mediated cytotoxicity.Progress of Inertial Microfluidics in Principle and Application.The Prognostic Role of Circulating Tumor Cells (CTCs) in Lung Cancer The Use of Microfluidic Technology for Cancer Applications and Liquid Biopsy

P2860

Q26748850-2FBA8382-FFB1-4ACE-B9F5-FF980FC8A8A9 Q26774808-250EF7F3-8B87-4EE4-A926-3AEAABDDB31A Q28066285-78311899-BADE-4FAF-B6F8-2236DA4341CC Q28077032-1D707B1F-F143-4812-956E-8121DBEE58C2 Q30357985-CFCB5C54-6A57-4F98-A8E4-45ABD30A7F1E Q30361741-74F8E7BB-DECD-4D00-A11B-9BE425005147 Q33902576-74A89078-6F4B-400F-BAB1-A2CD800233D3 Q36926601-7C25C494-C972-4166-BA34-ADDD4B37926D Q36983860-398B3B8B-455E-4960-B95D-D096F454282F Q37085811-32DF40A4-411C-4045-9669-EA0683D609E2 Q37115286-13929F75-2D3C-4546-AE26-262BD8F526EC Q37687598-A5E64519-4479-4B76-8988-9F8FB404F954 Q38549648-63A2F855-5FB0-4716-B2F1-89B107D0001B Q38637064-1E6AD9F4-A8E6-4895-B281-FC9153E44E7A Q38657288-E97D7AF4-68C2-4AC0-8D09-B3F402168254 Q38693785-C173FDE2-8D8B-48B3-9A94-17BD515FFF43 Q38701763-BC0F52EF-B019-4FDC-A32A-9C7D23A75E18 Q38742272-25C5BF87-EEA7-4A35-B8C3-BBBA6204EB01 Q38743200-60E102B7-EDB2-41BA-9333-C5E57B282494 Q38838108-C4343491-7D40-40B4-85A7-9082D2875479 Q39329818-C0057CF1-7BE3-48CA-BBF1-74C081A56E1F Q39385781-D28EC3D1-D7DC-4752-9BF2-B00BCCA3DB0B Q42253058-7EB1591A-1F38-48C8-92E8-8E2DD2EDD950 Q47273146-E70155B7-A5ED-4002-9025-B65E2C291B0E Q47415861-ECBDEBEB-507B-413F-B49D-947F43EE6837 Q47425176-AF919A53-A83E-4DB5-B09A-666D2FDFE57B Q47449116-AA0FD353-B5D3-44E2-B5C4-171B6BB5E455 Q48146199-96BBB072-8D10-400B-993D-181BE8F9538D Q50127876-2C99063C-53EB-4BE5-9E9E-A61AB8B1A33E Q50351390-0F98E605-AA30-424F-9192-CEEF10EEC856 Q50421816-01D1F0D7-512A-423D-8295-1D2E3CB960EB Q51462507-E0CCB6BE-8293-4B2A-ADC5-5F1ECCFAC912 Q52878180-0F8B4DC5-1173-400D-8937-B70407BAE807 Q53199357-3588DBF7-04AE-40D9-AC4E-E9CD131235C2 Q53399279-A79FCB56-CE1E-4425-BF5F-B4165817F4B5 Q55397677-9FA996F3-FC6B-44F8-9392-621A904B4ACB Q58781611-726912EE-61D4-47B3-9E04-07C98B2CD8E1 Q58788640-BC9E5136-65F8-4DC7-8E8D-C9E856B0EE82

P2860

Short-term expansion of breast circulating cancer cells predicts response to anti-cancer therapy.

http://www.wikidata.org/entity/Q35640863

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Short-term expansion of breast ...... sponse to anti-cancer therapy.

@ast

Short-term expansion of breast ...... sponse to anti-cancer therapy.

@en

type

label

Short-term expansion of breast ...... sponse to anti-cancer therapy.

@ast

Short-term expansion of breast ...... sponse to anti-cancer therapy.

@en

prefLabel

Short-term expansion of breast ...... sponse to anti-cancer therapy.

@ast

Short-term expansion of breast ...... sponse to anti-cancer therapy.

@en

P1433

Q35640863-F3008419-F735-4842-8D8D-A396A8028C22

P1476

Q35640863-1A6062D1-3BFA-4CAE-9218-4E4C54989A7E

P2093

Q35640863-0FAB714D-4AF8-4EF3-B8A1-A52AA40CC4F2

Q35640863-4533CC08-E75E-40F2-B761-09A845D208A7

Q35640863-47CAF340-B921-447A-8B0B-4C38AC2F3431

Q35640863-6BED4AFE-108E-4C59-985C-C8CAA99ABC1B

Q35640863-88DDF04A-A1DF-4254-A909-B680B59C797D

Q35640863-E87A2FDE-BDEA-4449-91D8-B81CD0C3A788

Q35640863-FB079453-3813-45CC-ADD1-107BB1D2CD97

Q35640863-FE213167-0629-4E07-97E4-A4521F48CEF7

P2860

Q35640863-02C0F82B-373C-4E36-B610-A06306676064

Q35640863-037328C7-1A98-40B4-8A2D-63B743C98E1A

Q35640863-089A03F1-31F6-4855-A943-7BA13CC3BB89

Q35640863-09530470-C6DB-4AAF-A133-6B7710A23438

Q35640863-0BC1EBCA-716E-4A03-BAE9-2BF2AFBDE01E

Q35640863-29AD21C7-D881-429A-BC13-3975F42F5EDA

Q35640863-2F7D0717-4640-4927-9413-5FC8EB110738

Q35640863-34058921-A8B8-4B4C-A306-042C3D542AE6

Q35640863-3681D6B2-A6F8-467B-B173-883568D2D7B9

Q35640863-36EEC551-1D00-4807-99F4-2E1B3E86CFDD

P304

Q35640863-25A1D7A6-578C-4DE8-B1F9-89430E600E44

P31

Q35640863-9965A4BD-F0D4-4C64-A10B-6FB6EC5F50B9

P356

Q35640863-E514CCA1-A8EA-42A9-8F88-652396056FA7

P407

Q35640863-0C48ED16-9698-4B30-B0D9-E30FB3560D26

P433

Q35640863-13C1CFB1-E09B-420A-887F-2827307FF7C2

P478

Q35640863-998AD661-A3D4-4690-9B95-116025D34504

P50

Q35640863-740DB5EF-4A89-48E7-B439-80B491CD8A72

P577

Q35640863-D94A58C2-9B80-4F74-9BCD-4500794EF43E

P5875

Q35640863-EE41BF6D-F757-430A-8FD5-0AB5873D70FD

P698

Q35640863-C8A81DAA-E66F-43E4-905E-A58CDC19F186

P932

Q35640863-2588424F-3FDD-49C3-AA17-EF5C4E45C59E

P356

ONCOTARGET.3903

P1433

P1476

Short-term expansion of breast ...... esponse to anti-cancer therapy

@en

P2093

Bee Luan Khoo

http://www.w3.org/2001/XMLSchema#string

Chwee Teck Lim

http://www.w3.org/2001/XMLSchema#string

Jean Paul Thiery

http://www.w3.org/2001/XMLSchema#string

Majid Ebrahimi Warkiani

http://www.w3.org/2001/XMLSchema#string

Prashant Kumar

http://www.w3.org/2001/XMLSchema#string

Sayantani Nandi

http://www.w3.org/2001/XMLSchema#string

Soo Chin Lee

http://www.w3.org/2001/XMLSchema#string

Tuan Zea Tan

http://www.w3.org/2001/XMLSchema#string

P2860

Isolation of rare circulating tumour cells in cancer patients by microchip technology

The epithelial-mesenchymal transition generates cells with properties of stem cells

Prospective identification of tumorigenic breast cancer cells

Epithelial-mesenchymal transitions in tumour progression

Mutations of the BRAF gene in human cancer

Relevance of breast cancer cell lines as models for breast tumours: an update

Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells

A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations

Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition

EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer

P304

15578-15593

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.3903

http://www.w3.org/2001/XMLSchema#string

P407

P433

17

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

277252116

http://www.w3.org/2001/XMLSchema#string

P698

26008969

http://www.w3.org/2001/XMLSchema#string

P932

4558172

http://www.w3.org/2001/XMLSchema#string